TRDN Gene Ventricular Tachycardia Catecholaminergic Polymorphic Type 5 Genetic Test
Components: TRDN Gene Ventricular tachycardia catecholaminergic polymorphic type 5 Genetic Test
Price: 4400.0 AED
Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test Type: Cardiovascular Pneumology Disorders
Doctor: Cardiologist
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for TRDN Gene Ventricular tachycardia, catecholaminergic polymorphic type 5 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with TRDN Gene Ventricular tachycardia, catecholaminergic polymorphic type 5 NGS Genetic DNA Test gene TRDN
Test Details: The TRDN gene is associated with a genetic condition called catecholaminergic polymorphic ventricular tachycardia type 5 (CPVT5). This condition is characterized by abnormal heart rhythms, specifically ventricular tachycardia, which can be life-threatening if not managed properly. NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that allows for the simultaneous analysis of multiple genes or the entire genome. In the case of CPVT5, NGS genetic testing can be used to identify mutations or variations in the TRDN gene that may be responsible for the condition. By analyzing the TRDN gene using NGS, healthcare professionals can determine if an individual has any genetic changes that are associated with CPVT5. This information can help with diagnosis, prognosis, and treatment planning for individuals with this condition.
Test Name | TRDN Gene Ventricular tachycardia catecholaminergic polymorphic type 5 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Cardiovascular Pneumology Disorders |
Doctor | Cardiologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for TRDN Gene Ventricular tachycardia, catecholaminergic polymorphic type 5 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with TRDN Gene Ventricular tachycardia, catecholaminergic polymorphic type 5 NGS Genetic DNA Test gene TRDN |
Test Details |
The TRDN gene is associated with a genetic condition called catecholaminergic polymorphic ventricular tachycardia type 5 (CPVT5). This condition is characterized by abnormal heart rhythms, specifically ventricular tachycardia, which can be life-threatening if not managed properly. NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that allows for the simultaneous analysis of multiple genes or the entire genome. In the case of CPVT5, NGS genetic testing can be used to identify mutations or variations in the TRDN gene that may be responsible for the condition. By analyzing the TRDN gene using NGS, healthcare professionals can determine if an individual has any genetic changes that are associated with CPVT5. This information can help with diagnosis, prognosis, and treatment planning for individuals with this condition. |